The Diaceutics PM Connective is on a mission to increase awareness about testing so that every patient is empowered to make the best possible decisions in his/her treatment journey.
This has the immediate implication that the diagnostic ecosystem needs to be modified. Through advocacy, patients will be the agents of change that will allow them to receive the right treatment, at the right time.
The Diaceutics PM Connective is a communications and advocacy platform, where all stakeholders in healthcare, embrace the better testing needs of patients and join efforts to upscale the reach of Precision Medicine. The Diaceutics PM Connective is led by a Patient Advocate and guided by its Board Members and the Strategic Task Force.
The Board and Strategic Task Force members of the Diaceutics PM Connective are leaders in the PM space, coming from all stakeholder spaces in healthcare. Their role is to guide the efforts of the Diaceutics PM Connective to success in its initiatives of increasing awareness and advocating for better testing practices.
The goal of the Diaceutics PM Connective is to continuously make alliances with different patient groups, to raise their voices in their specific diagnostic needs. At the same time, all these patient groups will join their voices, to advocate for their one communality:
To change current infrastructures to adopt better testing practices to accommodate patients’ needs to be able to make the best treatment decisions available to each of them.
Empowered patients are the driving force in modifying the diagnostic ecosystem that will ultimately allow each of them to receive the right treatment, at the right time.